Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine + liposomal bupivacaine fascia iliaca block for postoperative analgesia after hip arthroplasty in elderly
ChiCTR2600121044Phase 4Not yet recruiting
- Sponsor
- Luxian People's Hospital
- Start
- Mar 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in postoperative pain comparing liposomal bupivacaine + dexmedetomidine fascia iliaca block with Control: liposomal bupivacaine fascia iliaca block (2 arms). Primary endpoint: Pain intensity at rest and during movement. Planned start Mar 2026; status: not yet recruiting.
02
Drugs
dexmedetomidinebupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on ChiCTR2600121044.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600121044.